Cat.#: ASSD-170
| Description | BAPTA-AM is a cell-permeable Ca2+ chelator that can be hydrolyzed by cytosolic esterases. The compound is used for the manipulation of cellular Ca2+ levels. BAPTA analog. |
| Size | 25 mg |
| Chemical Name | 1,2-Bis(2-aminophenoxy)ethane-N,N,N ',N'-tetraacetic acid tetrakis(acetoxymethyl ester) |
| Molecule Weight | 764.68 |
| Molecular formula | C34H40N2O18 |
| CAS Number | 126150-97-8 |
| PubChem identifier | 2293 |
| Purity | >95% |
| Solubility | Soluble in DMSO (30mM) |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-115 | 7-Amino-4-methylcoumarin (AC115) | 100 mg, 500 mg, 1 g | inquiry |
| ASSD-141 | MTT (AC141) | 500 mg, 1 g | inquiry |
| ASSD-128 | Fluorescent M3 antagonist [pirenzepine] (AC128) | 50 μg | inquiry |
| ASSD-157 | Eosin B (AC157) | 1g, 5g | inquiry |
| ASSD-171 | Ionomycin calcium salt (AC171) | 1mg, 5mg | inquiry |
| ASSD-200 | Ethylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[3-difluoromethyl-4-phosphoanilinamidosuccinic Acid] Diamide (AC200) | 500 μg | inquiry |
| ASSD-224 | Antifade Fluorescence Mounting Medium with DAPI (aqueous) (AC224) | 10 mL | inquiry |
| ASSD-148 | Sulforhodamine 101 (AC148) | 50 mg, 100 mg | inquiry |
| ASSD-212 | 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212) | 25 mg | inquiry |
| ASSD-196 | 5-Carboxyfluorescein (AC196) | 100 mg, 250 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.